17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2
Alissa Brandes(Unknown), Sabrina M. Ronen(University of California, San Francisco)
Cited by 31
Related Papers
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology
|Neoplasia|2018|446
Non-invasive in vivo assessment of IDH1 mutational status in glioma
|Nature Communications|2013|142
Applications of Magnetic Resonance in Model Systems: Cancer Therapeutics
|Neoplasia|2000|133